164 related articles for article (PubMed ID: 30374014)
21. MiR-122 increases sensitivity of drug-resistant BEL-7402/5-FU cells to 5-fluorouracil via down-regulation of bcl-2 family proteins.
Yin J; Tang HF; Xiang Q; Yu J; Yang XY; Hu N; Lei XY
Pharmazie; 2011 Dec; 66(12):975-81. PubMed ID: 22312705
[TBL] [Abstract][Full Text] [Related]
22. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.
Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C
Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840
[TBL] [Abstract][Full Text] [Related]
23. Effect of miR-212 targeting TCF7L2 on the proliferation and metastasis of cervical cancer.
Zhou C; Tan DM; Chen L; Xu XY; Sun CC; Zong LJ; Han S; Zhang YZ
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):219-226. PubMed ID: 28165569
[TBL] [Abstract][Full Text] [Related]
24. [Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells].
Shi YR; Liu J; He W; Yang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):697-702. PubMed ID: 28598082
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
[TBL] [Abstract][Full Text] [Related]
26. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
[TBL] [Abstract][Full Text] [Related]
27. miR-375 Affects the Proliferation, Invasion, and Apoptosis of HPV16-Positive Human Cervical Cancer Cells by Targeting IGF-1R.
Yu X; Zhao W; Yang X; Wang Z; Hao M
Int J Gynecol Cancer; 2016 Jun; 26(5):851-8. PubMed ID: 27206217
[TBL] [Abstract][Full Text] [Related]
28. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
Yang F; Guo L; Cao Y; Li S; Li J; Liu M
Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
[TBL] [Abstract][Full Text] [Related]
30. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition.
Li LQ; Pan D; Chen Q; Zhang SW; Xie DY; Zheng XL; Chen H
Cell Physiol Biochem; 2018; 47(4):1533-1545. PubMed ID: 29940566
[TBL] [Abstract][Full Text] [Related]
31. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
33. Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.
Kurokawa K; Tanahashi T; Iima T; Yamamoto Y; Akaike Y; Nishida K; Masuda K; Kuwano Y; Murakami Y; Fukushima M; Rokutan K
J Gastroenterol; 2012 Aug; 47(8):883-95. PubMed ID: 22382630
[TBL] [Abstract][Full Text] [Related]
34. MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells.
Natalia MA; Alejandro GT; Virginia TJ; Alvarez-Salas LM
Microrna; 2018; 7(1):54-61. PubMed ID: 29076440
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
36. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
[TBL] [Abstract][Full Text] [Related]
37. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
38. RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway.
Liu Y; Li L; Liu Y; Geng P; Li G; Yang Y; Song H
J Cell Biochem; 2018 Apr; 119(4):3058-3066. PubMed ID: 29064588
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of the carboxylesterase 2 gene by the p53 pathway.
Choi W; Cogdell D; Feng Y; Hamilton SR; Zhang W
Cancer Biol Ther; 2006 Nov; 5(11):1450-6. PubMed ID: 16963839
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells.
Ghose J; Bhattacharyya NP
RNA Biol; 2015; 12(4):457-77. PubMed ID: 25757558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
